Open original FDA record ↗Recall record
- FDA identifier
- Z-0116-2017
- Company in FDA record
- St Jude Medical Inc.
- FDA classification date
- Oct 21, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
St Jude Medical is recalling implantable cardiac defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices because they are subject to premature battery depletion due to lithium cluster with the battery causing a short circuit.
Source facts
- Action
- St. Jude Medical, Inc., sent a customer letter to all affected customers to inform them that St. Jude Medical recently announced a global medical device advisory for a subset of their company's Fortify, Fortify Assura, Quadra Assura, Unify, Unify Assura and Unify Quadra implantable cardiac defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The letter informs customers that the cause for Premature Battery Depletion is attributed to the formation of lithium clusters within the battery causing a short circuit. There is a possibility that affected devices may lose battery power within days. Thus far, there have been two (2) deaths and ten (10) serious events (fainting) that may have been associated with premature battery depletion. Customers with questions were instructed to contact www.sjm.com/batteryadvisory, (866) 915-5065.
- Initiated
- 2016-10-10
- Root cause
- Device Design
- Terminated
- 2018-09-27
- Distribution
- Worldwide Distribution - US (nationwide) and OUS
- Recall number
- Z-0116-2017
- Recall status
- Terminated
- CDRH record ID
- 150192
- FDA classified
- 2016-10-21
- Recall event number
- 75393